Veranstaltung Ansichten-Navigation


What is Enough… Women in Clinical Trials?


On May 16, 2018 from 1:00 pm - 2:30 pm (Eastern Daylight Time EDT), join the FDA Office of Women’s Health for The Great Debate! Featuring Ellis F. Unger, M.D., FDA CDER, and Rita F. Redberg, M.D., M.Sc., F.A.C.C. The debate centers on cardiovascular disease clinical trials and the challenges and complexity of the question […]

Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender

FDA White Oak Campus, Bldg. 31, Great Room FDA’s White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503-A), Silver Spring, MD 20993

Sex differences may influence susceptibility to substance use disorders, which could have implications for optimal prevention and treatment. Gender influences also impact public health by influencing  rescription rates, care, and treatment-seeking behaviors. To identify and treat at-risk women, researchers, educators, and clinicians must be able to recognize and consider sex and gender differences in substance […]

BIH Excellence Award

Berlin Institute of Health Excellence Award for Sex and Gender Aspects in Health Research Apply until June 30, 2019! For the second time the Berlin Institute of Health announces the “BIH Excellence Award for Sex and Gender Aspects in Health Research”. The award aims to bring more visibility to sex and gender issues in translational […]

12. Jahrestagung der Österreichischen Gesellschaft für geschlechtsspezifische Medizin: Organismus & Technik – Spielt das Geschlecht eine Rolle?

Ärztekammer für Wien Weihburggasse 10-12, Wien

09:00 BIS 09:30 ERÖFFNUNG
Univ.-Prof. in Dr. in Alexandra Kautzky-Willer, Präsidentin der ÖGGSM
Prim. a Dr. in Hava Bugajer, Gründungsmitglied ÖGGSM, Präsidentin WIZO Österreich

„Geschlechtsspezifische Aspekte von Virtual Reality“
Univ.-Prof. Mag. DDr. Stefan Thurner